Results 191 to 200 of about 1,651 (200)
Some of the next articles are maybe not open access.
Alphavision: 12 points go to… Astatine-211
Background and purpose Alpha-emitting radionuclides and targeted alpha therapy (TAT) are transforming therapeutic and theragnostic nuclear medicine due to their high local dose delivery and possible minimal impact on surrounding healthy tissue. However, their clinical implementation faces challenges, due to complex decay schemes and suboptimal imaging ...Raes, Laurens +6 more
openaire +1 more source
Development of Astatine-211 labeling reaction using aryliodonium ylide
Nuclear Medicine and Biology, 2023Mikako Ogawa +6 more
openaire +1 more source
Astatine-211 colloid thearpy of experimental malignant ascites
International Journal of Radiation Oncology*Biology*Physics, 1980W.D. Bloomer +5 more
openaire +1 more source
Aryliodonium ylides as efficient precursors for astatine-211 labeling
Nuclear Medicine and Biology, 2022Clémence Maingueneau +6 more
openaire +1 more source
Development of UK Astatine‑211 Production Capability
Nuclear Medicine and BiologyJennifer Young +12 more
openaire +1 more source
Astatine-211: Endogenous Alpha-Radiotherapy for Thyroid Cancer
1996I. Brown, K. Randle
openaire +1 more source
Astatine-211-labeled compounds targeting fibroblast activation proteins
Nuclear Medicine and BiologyTomoya Uehara +5 more
openaire +1 more source
Towards automation of clinically relevant radiopharmaceuticals using astatine-211
Nuclear Medicine and BiologyEllinor Hansson +4 more
openaire +1 more source
Astatine-211 program at Texas A&M University
Nuclear Medicine and BiologySherry Yennello +11 more
openaire +1 more source